Neurologic paraneoplastic syndromes and anti-neuronal antibodies;Neurologiske paraneoplastiske syndromer og antineuron-antistoffer

Tidsskrift for den Norske Laegeforening

Volumn 116, Issue 3, 1996, Pages 361-365

  Mygland, Åse ^a  

^a Nevrologisk Avdeling   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; AUTOANTIBODY;

CEREBELLUM; DIFFERENTIAL DIAGNOSIS; HUMAN; IMMUNOLOGY; NERVE CELL; NERVE DEGENERATION; NEUROLOGIC DISEASE; PARANEOPLASTIC SYNDROME; PATHOLOGY; REVIEW;

ANTIBODIES; AUTOANTIBODIES; CEREBELLUM; DIAGNOSIS, DIFFERENTIAL; HUMANS; NERVE DEGENERATION; NERVOUS SYSTEM DISEASES; NEURONS; PARANEOPLASTIC SYNDROMES;

EID: 0030606371     PISSN: 00292001     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Anderson NE, Cunningham JM, Posner JB. Autoimmune pathogenesis of paraneoplastic neurological syndromes. Crit Rev Neurobiol 1987; 3: 245-99.
2. Posner JB, Furneaux HM. Paraneoplastic syndromes. I: Waksman BH, red. Immunologic mechanisms in neurologie and psychiatric disease. New York: Raven Press, 1990: 187-219.
3. Dropcho EJ. Autoimmune central nervous system paraneoplastic syndromes: mechanisms, diagnosis, and therapeutic options. Ann Neurol 1995; 37 (suppl 1): 102-3.
4. Henson RA, Urich H. Cancer and the nervous system. The neurological manifestations of systemic disease. Oxford: Blackwell Scientific, 1982: 346-67
5. Anderson NE, Rosenblum MK, Posner JB. Paraneoplastic cerebellar degeneration: clinical-immunological correlations. Ann Neurol 1988; 24: 559-67.
6. Peterson K, Rosenblum MK, Kotanides H, Posner JB. Paraneoplastic cerebellar degeneration. A clinical analysis of 55 anti-Yo antibody-positive patients. Neurology 1992; 42: 1931-7.
7. Hammack J, Kotanides H, Rosenblum MK, Posner JB. Paraneoplastic cerebellar degeneration. II. Clinical and immunological findings in 21 patients with Hodgkins disease. Neurology 1992; 42: 1938-43.
8. Anderson NE, Rosenblum MK, Graus F, Wiley RG, Posner JB. Autoantibodies in paraneoplastic syndromes associated with small-cell lung cancer. Neurology 1988; 38: 1391-8.
9. Clouston PD, Saper CB, Arbizu T, Johnston I, Lang B, Newsom-Davis J et al. Paraneoplastic cerebellar degeneration. III. Cerebellar degeneration, cancer, and the Lambert-Eaton myasthenic syndrome. Neurology 1992; 42: 1944-50.
10. Chalk CH, Windebank AJ, Kimmel DW, McManis PG. The distinctive clinical features of paraneoplastic sensory neuronopathy. Can J Neurol Sci 1992; 19: 346-51.
11. Graus F, Elkon KB, Cordon-Carlo C, Posner JB. Sensory neuronopathy and small cell lung cancer: antineuronal antibody that also reacts with the tumor. Am J Med 1986; 80: 45-52.
12. Dalmau J, Graus F, Rosenblum MK, Posner JB. Anti-Hu-associated paraneoplastic encephalomyelitis/sensory neuronopathy. A clinical study of 71 patients. Medicine 1992; 71: 59-72.
13. Bakheit AMO, Kennedy PGE, Behan PO. Paraneoplastic limbic encephalitis: clinico-pathological correlations. J Neurol Neurosurg Psychiatry 1990; 53: 1084-8.
14. Dirr LY, Elster AD, Donofrio PD, Smith M. Evolution of brain MRI abnormalities in limbic encephalitis. Neurology 1990; 40: 1304-6.
15. Musarella MA, Chan HSL, DeBoer G, Callie BL. Ocular involvement in neuroblastoma: prognostic implications. Ophtalmology 1984; 91: 936-40.
16. Glantz MJ, Biran H, Myers ME, Gockerman JP, Friedberg MH. The radiographic diagnosis and treatment of paraneoplastic central nervous system disease. Cancer 1994; 73: 168-75.
17. Luque FA, Furneaux HM, Ferziger R, Rosenblum MK, Wray SH, Schold C jr. et al. Anti-Ri: an antibody associated with paraneoplastic opsoclonus and breast cancer. Ann Neurol 1991; 29: 241-51.
18. O'Neill JH, Murray MF, Newsom-Davis J. The Lambert-Eaton myasthenic syndrome. A review of 50 cases. Brain 1988; 111: 577-96.
19. Vincent A, Lang B, Newsom-Davis J. Autoimmunity to the voltage-gated calcium channel underlies the Lambert-Eaton myasthenic syndrome, a paraneoplastic disorder. Trends Neurosci 1989; 12: 496-502.
20. Leys K, Lang B, Johnston I, Newsom-Davis J. Calcium channel autoantibodies in the Lambert-Eaton myasthenic syndrome. Ann Neurol 1991; 29: 307-14.
21. Lennon VA, Lambert EH. Autoantibodies bind solubilized calcium-channel-ω̄-conotoxin complexes from small cell lung carcinoma: a diagnostic aid for Lambert-Eaton myasthenic syndrome. Mayo Clin Proc 1989; 64: 1498-504.
22. Lennon VA. Paraneoplastic autoantibodies: the case for a descriptive generic nomenclature. Neurology 1994; 44: 2236-40.
23. Dalmau J, Posner JB. Neurologic paraneoplastic antibodies (anti-Yo; anti-Hu; anti-Ri): the case for a nomenclature based on antibody and antigen specificity. Neurology 1994; 44: 2241-6.
24. Greenlee JE, Brashear HR. Antibodies to cerebellar Purkinje cells in patients with paraneoplastic cerebellar degeneration and ovarian carcinoma. Ann Neurol 1983; 14: 609-13.
25. Cunningham J, Graus F, Anderson M, Posner JB. Partial characterization of the Purkinje cell antigens in paraneoplastic cerebellar degeneration. Neurology 1986; 36: 1163-8.
26. Furneaux HM, Rosenblum MK, Dalmau J, Wong E, Woodruff P, Graus F et al. Selective expression of Purkinje-cell antigens in tumor tissue from patients with paraneoplastic cerebellar degeneration. N Engl J Med 1990; 332: 1844-51.
27. Fathalla-Shaykh H, Wolf S, Wong E, Posner JB, Furneaux HM. Cloning of a leucine zipper protein recognized by the sera of patients with antibody-associated paraneoplastic cerebellar degeneration. Proc Natl Acad Sci USA 1991; 88: 3451-4.
28. Graus F, Gordon-Cardo C, Posner JB. Neuronal antinuclear antibody in sensory neuronopathy from lung cancer. Neurology 1985; 35: 538-43.
29. Dalmau J, Furneaux HM, Rosenblum MK, Graus F, Posner JB. Detection of anti-Hu antibody in specific regions of the nervous system and tumor from patients with paraneoplastic encephalomyelitis/sensory neuronopathy. Neurology 1991; 41: 1757-64.
30. Szabo A, Dalmau J, Manley G, Rosenfeld M, Wong E, Henson J et al. HuD, a paraneoplastic encephalomyelitis antigen, contains RNA-binding domains and is homologous to Elav and Sex-lethal. Cell 1991; 67: 325-33.
31. Manley GT, Sillevis-Smith PAE, Dalmau J, Posner JB. Molecular characterization of the Hu paraneoplastic encephalitis-related proteins in small-cell lung cancer tissues, and analysis of the major immunogenic sites. Neurology 1994; 44 (suppl 2): A156-7.
32. Dalmau J, Furneaux HM, Cordon-Cardo C, Posner JB. The expresssion of the Hu (paraneoplastic encephalomyelitis/sensory neuronopathy) antigen in human normal and tumor tissues. Am J Pathol 1992; 141: 881-6.
33. Lang B, Newsom-Davis J, Prior C, Wray D. Antibodies to motor nerve terminals: an electrophysiological study of human myasthenic syndrome transferred to mouse. J Physiol 1983; 344: 335-45.
34. Graus F, Illa I, Agusti M, Ribalta T, Cruz-Sanchez F, Juarez C. Effect of intraventricular injection of an anti-Purkinje cell antibody (anti-Yo) in a guinea pig model. J Neurol Sci 1991; 106: 82-7.
35. Graus F, Vega F, Delattre JY, Bonaventura I, René R, Arbaiza D et al. Plasmapheresis and anti-neoplastic treatment in CNS paraneoplastic syndromes with antineuronal autoantibodies. Neurology 1992; 42: 536-40.
36. Cocconi G, Ceci G, Juvarra G, Minopoli MR, Cocchi T, Fiaccadori F et al. Successful treatment of subacute cerebellar degeneration in ovarian carcinoma with plasmapheresis. Cancer 1985; 56: 2318-20.
37. Moll JW, Henzen-Logmans SC, van der Meche FGA, Vecht CH. Early diagnosis and intravenous immune globulin therapy in paraneoplastic cerebellar degeneration. J Neurol Neurosurg Psychiatry 1993; 56: 112.
38. Stark E, Wurster U, Patzold U, Sailer M, Haas J. Immunological and clinical response to immunosuppressive treatment in paraneoplastic cerebellar degeneration. Arch Neurol 1995; 52: 814-8.
39. Oh SJ, Dropcho EJ. Steroid-responsive paraneoplastic encephaloneuropathy. Neurology 1990; 40 (suppl 1): 246.
40. Batson OA, Fantle DM, Stewart JA. Paraneoplastic encephalomyelitis: dramatic response to chemoterapy alone. Cancer 1992; 69: 1291-3.
41. Dropcho EJ, Kline LB, Riser J. Antineuronal (anti-Ri) antibodies in a patient with steroid-responsive opsoclonus-myoclonus. Neurology 1993; 43: 207-11.
42. Herishanu Y, Apte R, Kuperman O. Immunological abnormalities in opsoclonus cerebellopathy. Neuroophtalmology 1985; 5: 271-5.
43. Nitschke M, Hochberg F, Dropcho E. Improvement of paraneoplastic opsoclonus-myoclonus after protein A column therapy N Engl J Med 1995; 332: 192.
44. Sanders DB. Lambert-Eaton myasthenic syndrome: clinical diagnosis, immune-mediated mechanisms, and update on therapies. Ann Neurol 1995; 37 (suppl 1): 63-73.